| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327659 | Gynecologic Oncology | 2005 | 6 Pages |
Abstract
The reported incidence of gemcitabine-induced HUS is rare. Clinicians should suspect HUS if blood pressure elevation or peripheral edema develop.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sharyn N. Lewin, David G. Mutch, Bradford P. Whitcomb, Helen Liapis, Thomas J. Herzog,